Curcumin attenuates glucose-induced monocyte chemoattractant protein-1 synthesis in aortic endothelial cells by modulating the nuclear factor-κB pathway

Pharmacology

Volumn 85, Issue 1, 2010, Pages 18-26

  Panicker, Sumith Retnamma ^a   Kartha, Chandrasekharan Cheranellore ^a  

^a SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Curcumin; Endothelial cell; High glucose; Losartan; Monocyte chemoattractant protein 1; Nuclear factor B; Sodium salicylate

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; CURCUMIN; DNA; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOSARTAN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SALICYLATE SODIUM; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA BINDING; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; AORTA; CHEMOKINE CCL2; CURCUMIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; LOSARTAN; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SODIUM SALICYLATE;

EID: 70849084248     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000262325     Document Type: Article

References (36)

1. Laakso M: Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-942. (Pubitemid 29226337)
2. Chait A, Bornfeldt KE: Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 2009; 50:S335-S339.
3. Weber C, Schober A, Zernecke A: Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 1997-2008.
4. Shin WS, Szuba A, Rockson SG: The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002; 160: 91-102.
5. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF: MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 1999; 103: 773-778.
6. Aiello RJ, Bourassa PA, Lindsey S, Weng W, Natoli E, Rollins BJ, Milos PM: Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1999; 19: 1518-1525.
7. Mine S, Okada Y, Tanikawa T, Kawahara C, Tabata T, Tanaka Y: Increased expression levels of monocyte CCR2 and monocyte chemoattractant protein-1 in patients with diabetes mellitus. Biochem Biophys Res Commun 2006; 344: 780-785.
8. Shanmugam N, Reddy MA, Guha M, Natarajan R: High glucose-induced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003; 52: 1256-1264.
9. Luppi P, Cifarelli V, Tse H, Piganelli J, Trucco M: Human C-peptide antagonises high glucose-induced endothelial dysfunction through the nuclear factor-κ B pathway. Diabetologia 2008; 51: 1534-1543.
10. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T: Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 2007; 193: 328-334.
11. Sarkar FH, Li Y, Wang Z, Kong D: NF-κ B signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol 2008; 27: 293-319.
12. Maheshwari RK, Singh AK, Gaddipati J, Srimal RC: Multiple biological activities of curcumin: a short review. Life Sci 2006; 78: 2081-2087.
13. Ammon HP, Wahl MA: Pharmacology of Curcuma longa. Planta Med 1991; 57: 1-7.
14. Bengmark S: Curcumin, an atoxic antioxidant and natural NFκ B, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. JPEN J Parenter Enteral Nutr 2006; 30: 45-51.
15. Kim YS, Ahn Y, Hong MH, Joo SY, Kim KH, Sohn IS, Park HW, Hong YJ, Kim JH, Kim W, Jeong MH, Cho JG, Park JC, Kang JC: Curcumin attenuates inflammatory responses of TNF-α-stimulated human endothelial cells. J Cardiovasc Pharmacol 2007; 50: 41-49.
16. Bian F, Zhang MC, Zhu Y: Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Ophthalmologica 2008; 222: 178-186.
17. Ensafi AA, Hajian R: Determination of losartan and triamterene in pharmaceutical compounds and urine using cathodic adsorptive stripping voltammetry. Anal Sci 2008; 24: 1449-1454.
18. Awtry EH, Loscalzo J: Aspirin. Circulation 2000; 101: 1206-1218.
19. Khan Q, Mehta JL: Relevance of platelet-independent effects of aspirin to its salutary effect in atherosclerosis-related events. J Atheroscler Thromb 2005; 12: 185-190.
20. Mehta JL, Chen J, Yu F, Li DY: Aspirin inhibits ox-LDL-mediated LOX-1 expression and metalloproteinase-1 in human coronary endothelial cells. Cardiovasc Res 2004; 64: 243-249.
21. Kopp E, Ghosh S: Inhibition of NF-κ B by sodium salicylate and aspirin. Science 1994; 265: 956-959.
22. McGuire PG, Orkin RW: Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrata. Lab Invest 1987; 57: 94-105.
23. Kodama K, Nishio Y, Sekine O, Sato Y, Egawa K, Maegawa H, Kashiwagi A: Bidirectional regulation of monocyte chemoattractant protein-1 gene at distinct sites of its promoter by nitric oxide in vascular smooth muscle cells. Am J Physiol Cell Physiol 2005; 289: C582-C590.
24. Nair A, Venkatraman M, Maliekal TT, Nair B, Karunagaran D: NF-κ B is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene 2003; 22: 50-58.
25. Anto RJ, Venkatraman M, Karunagaran D: Inhibition of NF-κ B sensitizes A431 cells to epidermal growth factor-induced apoptosis, whereas its activation by ectopic expression of RelA confers resistance. J Biol Chem 2003; 278: 25490-25498.
26. Takaishi H, Taniguchi T, Takahashi A, Ishikawa Y, Yokoyama M: High glucose accelerates MCP-1 production via p38 MAPK in vascular endothelial cells. Biochem Biophys Res Commun 2003; 305: 122-128.
27. Dragomir E, Simionescu M: Monocyte chemoattractant protein-1-a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006; 112: 239-244.
28. Dragomir E, Manduteanu I, Calin M, Gan AM, Stan D, Koenen RR, Weber C, Simionescu M: High glucose conditions induce upregulation of fractalkine and monocyte chemotactic protein-1 in human smooth muscle cells. Thromb Haemost 2008; 100: 1155-1165.
29. Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC: Lipopolysaccharide- induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-κ B dependent. Kidney Int 2000; 57: 2011-2022.
30. Viatour P, Merville MP, Bours V, Chariot A: Phosphorylation of NF-κ B and Iκ B proteins: implications in cancer and inflammation. Trends Biochem Sci 2005; 30: 43-52.
31. Ohkita M, Takaoka M, Shiota Y, Nojiri R, Sugii M, Matsumura Y: A nuclear factor-κ B inhibitor BAY 11-7082 suppresses endothelin-1 production in cultured vascular endothelial cells. Jpn J Pharmacol 2002; 89: 81-84.
32. Farhangkhoee H, Khan ZA, Chen S, Chakrabarti S: Differential effects of curcumin on vasoactive factors in the diabetic rat heart. Nutr Metab (Lond) 2006; 3: 27.
33. Chang LT, Sun CK, Chiang CH, Wu CJ, Chua S, Yip HK: Impact of simvastatin and losartan on antiinflammatory effect: in vitro study. J Cardiovasc Pharmacol 2007; 49: 20-26.
34. Babu PS, Srinivasan K: Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin-induced diabetic rats. Mol Cell Biochem 1997; 166: 169-175.
35. Balasubramanyam M, Koteswari AA, Kumar RS, Monickaraj SF, Maheswari JU, Mohan V: Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 2003; 28: 715-721.
36. Sajithlal GB, Chithra P, Chandrakasan G: Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 1998; 56: 1607-1614.